Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
EMJ GOLD
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
The Middle East conflict: pharma’s supply chain stress test
The conflict is disrupting critical air freight routes, exposing vulnerabilities for biologics and low-margin generics.
Read more
Pharma marketing: What’s working for HCPs in 2025
Pharma marketing experts reveal what’s working to engage time-pressed HCPs in 2025, with practical insights and metrics for improving impact.
5 minutes with Dr Henar Hevia, J&J Innovative Medicine
Henar Hevia, Senior Director, EMEA Therapeutic Area Lead, Oncology, reveals what it’s like to work in oncology today, especially at J&J.
BMS’ Emma Charles on access, impact and inclusion
Emma shares her vision for healthcare, how AI is reshaping pharma and why access to innovation must be faster and fairer in Europe.
Pharma’s role in the rise of wellness misinformation
Wellness trends are outpacing science and endangering lives. As trust in traditional medicine erodes, pharma must step in to correct the narrative.
5 minutes with Graham Clark, CEO, Phastar
Graham Clark, CEO, Phastar, explores the current state of play in clinical research, the future of AI in the field and values-based business.
Pharma seized the spotlight at Cannes Lions – here's why
In a departure from years past, Cannes Lions 2025 saved a sizable percentage of their praise for companies in the pharma space.
Philips’ Dr Carla Goulart Peron on AI, equity and the future of care
How can AI expand healthcare access without losing the human touch? Philips’ CMO Dr Carla Goulart Peron shares all.
Education or promotion: What wins with HCPs?
When every second of a healthcare professional’s time counts, what content truly earns their attention – disease awareness or product promotion?
Medical affairs: What's working for HCPs in 2025
Four medical affairs leaders reveal what’s working (and what’s not) when it comes to engaging time-starved HCPs in 2025.
5 minutes with Andrew Cooper, CEO, CluePoints
Discover Andrew Cooper’s passion for optimising clinical trials with AI, driving innovation and building a culture of teamwork and purpose.
Hidden heroes of healthcare: Reaching NPs and PAs
Nurse practitioners and physician assistants are vital players in US healthcare, yet the industry often overlooks them.
5 minutes with Dr Tami Nussbaum, Takeda
Dr Tami Nussbaum, shares why she left medicine for pharma, the challenges of rare disease and how she avoids burnout.
5 minutes with... Kate Lenik, Chiesi
Kate Lenik shares her journey into HR, the evolving pharma workplace, and the secrets behind Chiesi’s award-winning culture.
The clock, the germ and the gut: Pharma’s role in healthy ageing
How pharma could shift from curing disease to promoting healthy ageing through epigenetics, the microbiome and antimicrobial innovation.
Pharma’s trillion-dollar opportunity: Investing in women’s health
Women’s health remains chronically underfunded, yet closing the gap could unlock huge value for women and the global economy.
5 minutes with Prof Alexander Egeberg, LEO Pharma
Prof Alexander Egeberg, Vice President, Head of Global Medical Affairs, LEO Pharma, reveals how the company is tackling unmet needs in dermatology.
Tackling bias, driving change: a roundtable for International Women’s Day
How can the pharmaceutical industry ‘Accelerate Action’ on gender parity this International Women’s Day? Find out now.
Chiesi’s Enrico Piccinini on driving action for Rare Disease Day
Find out what the Senior Vice President, EU & International, Rare Diseases, Chiesi Group, thinks the pharma industry should consider on Rare Disease Day.
5 minutes with... Jaime Manzanera, Eisai
Jaime Manzanera, EMEA Brand Director, Oncology, Eisai, shares his perspective on maximising ROI in pharmaceutical marketing and more.
Engaging the medical mind: Does interactivity improve recall?
Recall matters when it comes to medical content. Find out how knowledge can be better retained through interactive medical education.
5 minutes with... Dr Matthew Hickling, Allergan Aesthetics
Dr Matthew Hickling explores the science behind beauty, his role in aesthetics and the opportunities shaping the future of the field.
The changing face of field medical affairs
There are many pillars of medical affairs, but field teams are where the action happens. How do you build teams that deliver results?
Hook, line and sinker: Catching the attention of HCPs
Attention is the new currency in pharma marketing. With HCPs overwhelmed by information, delivering engaging content is crucial to standing out.
Building a high performance customer experience model
In the pharmaceutical industry, improving customer experience has become the goal, but it’s time to look at it in a new way.
Loading posts...
« Previous
1
…
3
4
5
6
7
…
36
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View